BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26923328)

  • 1. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
    Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
    Oncogene; 2016 Sep; 35(38):5000-9. PubMed ID: 26923328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
    Cardnell RJ; Behrens C; Diao L; Fan Y; Tang X; Tong P; Minna JD; Mills GB; Heymach JV; Wistuba II; Wang J; Byers LA
    Clin Cancer Res; 2015 Aug; 21(15):3480-91. PubMed ID: 25878335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma.
    Hu S; Yuan Y; Yan R; Xie H; Cai R; Xu J
    Biochem Biophys Res Commun; 2024 May; 708():149798. PubMed ID: 38518721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
    Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
    Oncogene; 2017 Aug; 36(35):5083. PubMed ID: 28604754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
    Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
    Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
    Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
    Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis.
    Akatsu Y; Yoshimatsu Y; Tomizawa T; Takahashi K; Katsura A; Miyazono K; Watabe T
    Cancer Sci; 2017 Jan; 108(1):151-155. PubMed ID: 28133920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
    Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
    Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.
    Rokavec M; Kaller M; Horst D; Hermeking H
    Sci Rep; 2017 Jul; 7(1):4687. PubMed ID: 28680090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition.
    Yang Y; Park JW; Bebee TW; Warzecha CC; Guo Y; Shang X; Xing Y; Carstens RP
    Mol Cell Biol; 2016 Jun; 36(11):1704-19. PubMed ID: 27044866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of TGF-β-mediated endothelial-mesenchymal transition by microRNA-27.
    Suzuki HI; Katsura A; Mihira H; Horie M; Saito A; Miyazono K
    J Biochem; 2017 May; 161(5):417-420. PubMed ID: 28338957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: NRF2 regulates serine biosynthesis in non-small cell lung cancer.
    DeNicola GM; Chen PH; Mullarky E; Sudderth JA; Hu Z; Wu D; Tang H; Xie Y; Asara JM; Huffman KE; Wistuba II; Minna JD; DeBerardinis RJ; Cantley LC
    Nat Genet; 2016 Apr; 48(4):473. PubMed ID: 27023779
    [No Abstract]   [Full Text] [Related]  

  • 13. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
    Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
    Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.
    Bott LC; Badders NM; Chen KL; Harmison GG; Bautista E; Shih CC; Katsuno M; Sobue G; Taylor JP; Dantuma NP; Fischbeck KH; Rinaldi C
    Hum Mol Genet; 2016 May; 25(10):1979-1989. PubMed ID: 26962150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor ATF4 directs basal and stress-induced gene expression in the unfolded protein response and cholesterol metabolism in the liver.
    Fusakio ME; Willy JA; Wang Y; Mirek ET; Al Baghdadi RJ; Adams CM; Anthony TG; Wek RC
    Mol Biol Cell; 2016 May; 27(9):1536-51. PubMed ID: 26960794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.
    Camarda R; Zhou AY; Kohnz RA; Balakrishnan S; Mahieu C; Anderton B; Eyob H; Kajimura S; Tward A; Krings G; Nomura DK; Goga A
    Nat Med; 2016 Apr; 22(4):427-32. PubMed ID: 26950360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.
    Park JH; Vithayathil S; Kumar S; Sung PL; Dobrolecki LE; Putluri V; Bhat VB; Bhowmik SK; Gupta V; Arora K; Wu D; Tsouko E; Zhang Y; Maity S; Donti TR; Graham BH; Frigo DE; Coarfa C; Yotnda P; Putluri N; Sreekumar A; Lewis MT; Creighton CJ; Wong LC; Kaipparettu BA
    Cell Rep; 2016 Mar; 14(9):2154-2165. PubMed ID: 26923594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.
    Lu K; Alcivar AL; Ma J; Foo TK; Zywea S; Mahdi A; Huo Y; Kensler TW; Gatza ML; Xia B
    Cancer Res; 2017 Jun; 77(11):2881-2892. PubMed ID: 28416489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
    Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-153 Regulates NRF2 Expression and is Associated with Breast Carcinogenesis.
    Wang B; Teng Y; Liu Q
    Clin Lab; 2016; 62(1-2):39-47. PubMed ID: 27012032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.